Gene expression profile of multiple myeloma cell line treated by Realgar

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 2, 2006, Pages 243-249

  Wang, M C ^a   Liu, S X ^a   Liu, Pengbo ^b,c  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Microarray; Multiple myeloma; Realgar

Indexed keywords

CARRIER PROTEIN; CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; GAP JUNCTION ALPHA 7 PROTEIN; GLUTAREDOXIN; HEAT SHOCK 70KDA PROTEIN 9B; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105KDA; HEAT SHOCK PROTEIN 110; HERBACEOUS AGENT; KININOGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; ORGANIC ANION TRANSPORTER 1; PLANT EXTRACT; PROTEIN SOLUTE CARRIER FAMILY 38 MEMBER 2; PROTEIN SOLUTE CARRIER FAMILY 7 MEMBER 5; REALGAR EXTRACT; SECRETED PHOSPHOPROTEIN 1; SOLUTE CARRIER FAMILY 38 MEMBER 2; SOLUTE CARRIER FAMILY 7 MEMBER 5; SOMATOMEDIN BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL FUNCTION; CELL GROWTH; CHINESE HERB; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HOMEOSTASIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MULTIPLE MYELOMA; MUSCLE CONTRACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ARSENICALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; MULTIPLE MYELOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFIDES; TUMOR CELLS, CULTURED;

EID: 33746347660     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dalton W. S.,: Targeting the mitochondria: an exciting new approach to myeloma therapy. Commentary re: N. J. Bahlis et al., Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clin. Cancer Res. 8: 3658-3668, 2002.
2. Bahlis N. J., McCafferty-Grad J., Jordan-McMurry I., et al.: Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clin. Cancer Res. 8:3658-3668, 2002.
3. Soignet S. L., Maslak P., Wang Z.G., et al.: Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339:1341-1348, 1998.
4. Soignet S. L., Frankel S.R., Douer D., et al.: United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J. Clin. Oncol. 19:3852-3860, 2001.
5. Pandit S., and Vesole D.H.: Relapsed multiple myeloma. Curr. Treat Options Oncol. 2:261-269, 2001.
6. Grad J. M., Bahlis N.J., Reis I., Oshiro M.M., Dalton W.S., Boise L.H.: Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood 98:805-813, 2001.
7. Jia P., Chen G., Huang X., et al.: Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Chin. Med. J. (Engl) 114:19-24, 2001.
8. Conti I and Rollins B.J.: CCL2 and cancer. Seminars in Cancer Biology 14:149-154, 2004.
9. Rollins B. J., Sunday M.E.: Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell Biol. 11:3125-3131, 1991.
10. Walter S., Bottazzi B., Govoni D., Colotta F., Mantovani A.: Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer 49:431-435, 1991.
11. Manome Y., Wen P. Y., Hershowitz A., et al.: Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 41:227-235, 1995.
12. Jourdan M., Tarte K., Legouffe E., Brochier J., Rossi J.F., Klein B.: TNF is a survival and proliferation factor for human myeloma cells. Eur. Cytokine Netw. 10:65-70, 1999.
13. Dmoszynska A., Bojarska-Junak A., Domanski D., Rolinski J., Hus M., Soroka-Wojtaszko M.: Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma. Leuk. Lymphoma. 43:401-406, 2002.
14. Jurisic V., Colovic M.: Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta2-microglobulin, and clinical stage in multiple myeloma. Med. Oncol. 19:133-139, 2002.
15. Kast R.E.: Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities-the role of bupropion. Leuk. Res. 29:1459-1463, 2005.
16. Zou J.X., Braun J., Sieper J.: Immunological basis for the use of TNF-alpha blocking agents in ankylosing spondylitis and immunological changes during treatment. Clin. Exp. Rheumatol. 20:S34-S37, 2002.
17. Zou J., Rudwaleit M., Brandt J., Thiel A., Braun J., Sieper J.: Up-regulation of the production of TNF-alpha and IFN-gamma by T cells in ankylosing spondylitis during treatment with etanercept. Ann. Rheum. Dis. 62:561-564, 2003.
18. Madhusudan S., Foster M., Muthuramalingam S.R., et al.: A phase II study of etanercept (Enbrel), a TNF-alpha inhibitor in patients with metastatic breast cancer. Clin. Cancer Res. 10:6528-6534, 2004.
19. Juan H.F., Lin J. Y., Chang W.H., et al.: Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods. Electrophoresis 23:2490-2504, 2002.
20. Yoshida N.L., Miyashita T., Yamada M., Reed J.C., Sugita Y., Oshida T.: Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem. Biophys. Res. Commun. 293:1254-1261, 2002.
21. Savli H., Aalto Y., Nagy B., Knuutila S., Pakkala S.: Gene expression analysis of 1,25(OH)2D3-dependent differentiation of HL-60 cells: a cDNA array study. Br. J. Haematol. 118:1065-1670, 2002.
22. Cho J., Kim J.J., Park S.G., et al.: Identification of B-cell translocation gene 1 as a biomarker for monitoring the remission of acute myeloid leukemia. Proteomics. 4:3456-3463, 2004.